nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—CHRM5—Tiotropium—chronic obstructive pulmonary disease	0.173	0.239	CbGbCtD
Oxybutynin—CHRM3—Tiotropium—chronic obstructive pulmonary disease	0.111	0.153	CbGbCtD
Oxybutynin—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.0964	0.133	CbGbCtD
Oxybutynin—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.0889	0.122	CbGbCtD
Oxybutynin—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0432	0.0595	CbGbCtD
Oxybutynin—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0364	0.0501	CbGbCtD
Oxybutynin—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0364	0.0501	CbGbCtD
Oxybutynin—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0324	0.0446	CbGbCtD
Oxybutynin—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0305	0.042	CbGbCtD
Oxybutynin—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0206	0.0284	CbGbCtD
Oxybutynin—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0197	0.0271	CbGbCtD
Oxybutynin—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0175	0.0241	CbGbCtD
Oxybutynin—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0103	0.0142	CbGbCtD
Oxybutynin—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00971	0.0134	CbGbCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000262	0.00115	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000262	0.00115	CcSEcCtD
Oxybutynin—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000261	0.00115	CcSEcCtD
Oxybutynin—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000261	0.00115	CcSEcCtD
Oxybutynin—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.00114	CcSEcCtD
Oxybutynin—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000259	0.00114	CcSEcCtD
Oxybutynin—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000258	0.00113	CcSEcCtD
Oxybutynin—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000258	0.00113	CcSEcCtD
Oxybutynin—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000258	0.00113	CcSEcCtD
Oxybutynin—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.00113	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000257	0.00113	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000256	0.00113	CcSEcCtD
Oxybutynin—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000256	0.00112	CcSEcCtD
Oxybutynin—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.00112	CcSEcCtD
Oxybutynin—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000255	0.00112	CcSEcCtD
Oxybutynin—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000253	0.00111	CcSEcCtD
Oxybutynin—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000253	0.00111	CcSEcCtD
Oxybutynin—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000253	0.00111	CcSEcCtD
Oxybutynin—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000253	0.00111	CcSEcCtD
Oxybutynin—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000253	0.00111	CcSEcCtD
Oxybutynin—Infection—Formoterol—chronic obstructive pulmonary disease	0.000251	0.0011	CcSEcCtD
Oxybutynin—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000251	0.0011	CcSEcCtD
Oxybutynin—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000249	0.00109	CcSEcCtD
Oxybutynin—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000249	0.00109	CcSEcCtD
Oxybutynin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000249	0.00109	CcSEcCtD
Oxybutynin—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000248	0.00109	CcSEcCtD
Oxybutynin—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000248	0.00109	CcSEcCtD
Oxybutynin—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000248	0.00109	CcSEcCtD
Oxybutynin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000248	0.00109	CcSEcCtD
Oxybutynin—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000248	0.00109	CcSEcCtD
Oxybutynin—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000248	0.00109	CcSEcCtD
Oxybutynin—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000247	0.00108	CcSEcCtD
Oxybutynin—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000247	0.00108	CcSEcCtD
Oxybutynin—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000246	0.00108	CcSEcCtD
Oxybutynin—Infection—Montelukast—chronic obstructive pulmonary disease	0.000246	0.00108	CcSEcCtD
Oxybutynin—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000246	0.00108	CcSEcCtD
Oxybutynin—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000246	0.00108	CcSEcCtD
Oxybutynin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000245	0.00108	CcSEcCtD
Oxybutynin—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.00107	CcSEcCtD
Oxybutynin—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000243	0.00107	CcSEcCtD
Oxybutynin—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000243	0.00107	CcSEcCtD
Oxybutynin—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000243	0.00107	CcSEcCtD
Oxybutynin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000241	0.00106	CcSEcCtD
Oxybutynin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.00105	CcSEcCtD
Oxybutynin—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.00105	CcSEcCtD
Oxybutynin—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.00104	CcSEcCtD
Oxybutynin—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.00104	CcSEcCtD
Oxybutynin—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000236	0.00104	CcSEcCtD
Oxybutynin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000235	0.00103	CcSEcCtD
Oxybutynin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000235	0.00103	CcSEcCtD
Oxybutynin—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00103	CcSEcCtD
Oxybutynin—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000233	0.00102	CcSEcCtD
Oxybutynin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.00102	CcSEcCtD
Oxybutynin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000231	0.00101	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000231	0.00101	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000231	0.00101	CcSEcCtD
Oxybutynin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000229	0.00101	CcSEcCtD
Oxybutynin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000229	0.00101	CcSEcCtD
Oxybutynin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000228	0.001	CcSEcCtD
Oxybutynin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000228	0.000999	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000226	0.000992	CcSEcCtD
Oxybutynin—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000225	0.000988	CcSEcCtD
Oxybutynin—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000225	0.000988	CcSEcCtD
Oxybutynin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000224	0.000985	CcSEcCtD
Oxybutynin—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.000981	CcSEcCtD
Oxybutynin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000223	0.000979	CcSEcCtD
Oxybutynin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000223	0.000979	CcSEcCtD
Oxybutynin—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000223	0.000978	CcSEcCtD
Oxybutynin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000222	0.000975	CcSEcCtD
Oxybutynin—Injury—Prednisone—chronic obstructive pulmonary disease	0.00022	0.000968	CcSEcCtD
Oxybutynin—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00022	0.000968	CcSEcCtD
Oxybutynin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00022	0.000966	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000218	0.00096	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000218	0.00096	CcSEcCtD
Oxybutynin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000218	0.000958	CcSEcCtD
Oxybutynin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000218	0.000958	CcSEcCtD
Oxybutynin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000218	0.000958	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000218	0.000956	CcSEcCtD
Oxybutynin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000216	0.000951	CcSEcCtD
Oxybutynin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.000951	CcSEcCtD
Oxybutynin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.000951	CcSEcCtD
Oxybutynin—Pain—Formoterol—chronic obstructive pulmonary disease	0.000216	0.000951	CcSEcCtD
Oxybutynin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000216	0.000949	CcSEcCtD
Oxybutynin—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000216	0.000947	CcSEcCtD
Oxybutynin—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000216	0.000947	CcSEcCtD
Oxybutynin—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000215	0.000943	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000214	0.00094	CcSEcCtD
Oxybutynin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000214	0.000939	CcSEcCtD
Oxybutynin—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.000933	CcSEcCtD
Oxybutynin—Pain—Montelukast—chronic obstructive pulmonary disease	0.000212	0.000931	CcSEcCtD
Oxybutynin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000211	0.000929	CcSEcCtD
Oxybutynin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.000924	CcSEcCtD
Oxybutynin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00021	0.000921	CcSEcCtD
Oxybutynin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000209	0.00092	CcSEcCtD
Oxybutynin—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.000918	CcSEcCtD
Oxybutynin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000209	0.000916	CcSEcCtD
Oxybutynin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000209	0.000916	CcSEcCtD
Oxybutynin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000208	0.000915	CcSEcCtD
Oxybutynin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000208	0.000912	CcSEcCtD
Oxybutynin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000207	0.000911	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000207	0.000909	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000207	0.000909	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.000906	CcSEcCtD
Oxybutynin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.000905	CcSEcCtD
Oxybutynin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.000898	CcSEcCtD
Oxybutynin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.000898	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000203	0.00089	CcSEcCtD
Oxybutynin—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000203	0.00089	CcSEcCtD
Oxybutynin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000201	0.000883	CcSEcCtD
Oxybutynin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.000883	CcSEcCtD
Oxybutynin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.0002	0.000879	CcSEcCtD
Oxybutynin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.000879	CcSEcCtD
Oxybutynin—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000199	0.000876	CcSEcCtD
Oxybutynin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000199	0.000876	CcSEcCtD
Oxybutynin—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000198	0.000869	CcSEcCtD
Oxybutynin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000198	0.000869	CcSEcCtD
Oxybutynin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000198	0.000868	CcSEcCtD
Oxybutynin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000198	0.000868	CcSEcCtD
Oxybutynin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000197	0.000865	CcSEcCtD
Oxybutynin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.000865	CcSEcCtD
Oxybutynin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000196	0.000863	CcSEcCtD
Oxybutynin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000196	0.000861	CcSEcCtD
Oxybutynin—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000196	0.000859	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.000858	CcSEcCtD
Oxybutynin—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000192	0.000843	CcSEcCtD
Oxybutynin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.000834	CcSEcCtD
Oxybutynin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00083	CcSEcCtD
Oxybutynin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000186	0.000819	CcSEcCtD
Oxybutynin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000186	0.000819	CcSEcCtD
Oxybutynin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000186	0.000818	CcSEcCtD
Oxybutynin—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.000817	CcSEcCtD
Oxybutynin—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000186	0.000816	CcSEcCtD
Oxybutynin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000183	0.000802	CcSEcCtD
Oxybutynin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000182	0.000798	CcSEcCtD
Oxybutynin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000182	0.000798	CcSEcCtD
Oxybutynin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000179	0.000786	CcSEcCtD
Oxybutynin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.000786	CcSEcCtD
Oxybutynin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000178	0.000781	CcSEcCtD
Oxybutynin—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000774	CcSEcCtD
Oxybutynin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.000773	CcSEcCtD
Oxybutynin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000175	0.00077	CcSEcCtD
Oxybutynin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000173	0.000761	CcSEcCtD
Oxybutynin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000173	0.000761	CcSEcCtD
Oxybutynin—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.000757	CcSEcCtD
Oxybutynin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.000753	CcSEcCtD
Oxybutynin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00017	0.000745	CcSEcCtD
Oxybutynin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.000743	CcSEcCtD
Oxybutynin—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000168	0.000738	CcSEcCtD
Oxybutynin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000167	0.000735	CcSEcCtD
Oxybutynin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.000735	CcSEcCtD
Oxybutynin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000164	0.00072	CcSEcCtD
Oxybutynin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.000718	CcSEcCtD
Oxybutynin—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000709	CcSEcCtD
Oxybutynin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.000707	CcSEcCtD
Oxybutynin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000161	0.000707	CcSEcCtD
Oxybutynin—Rash—Formoterol—chronic obstructive pulmonary disease	0.00016	0.000701	CcSEcCtD
Oxybutynin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.000701	CcSEcCtD
Oxybutynin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000159	0.0007	CcSEcCtD
Oxybutynin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.0007	CcSEcCtD
Oxybutynin—Headache—Formoterol—chronic obstructive pulmonary disease	0.000159	0.000696	CcSEcCtD
Oxybutynin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.000696	CcSEcCtD
Oxybutynin—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000158	0.000695	CcSEcCtD
Oxybutynin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.000694	CcSEcCtD
Oxybutynin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000158	0.000692	CcSEcCtD
Oxybutynin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000156	0.000687	CcSEcCtD
Oxybutynin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000156	0.000686	CcSEcCtD
Oxybutynin—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.000684	CcSEcCtD
Oxybutynin—Depression—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000684	CcSEcCtD
Oxybutynin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000155	0.000682	CcSEcCtD
Oxybutynin—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.000674	CcSEcCtD
Oxybutynin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.000667	CcSEcCtD
Oxybutynin—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.000665	CcSEcCtD
Oxybutynin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.000662	CcSEcCtD
Oxybutynin—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.000662	CcSEcCtD
Oxybutynin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.000661	CcSEcCtD
Oxybutynin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00015	0.00066	CcSEcCtD
Oxybutynin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00015	0.00066	CcSEcCtD
Oxybutynin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.000658	CcSEcCtD
Oxybutynin—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.000648	CcSEcCtD
Oxybutynin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000147	0.000647	CcSEcCtD
Oxybutynin—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000146	0.000639	CcSEcCtD
Oxybutynin—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000145	0.000637	CcSEcCtD
Oxybutynin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.000623	CcSEcCtD
Oxybutynin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.00062	CcSEcCtD
Oxybutynin—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000613	CcSEcCtD
Oxybutynin—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000605	CcSEcCtD
Oxybutynin—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.000602	CcSEcCtD
Oxybutynin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.000602	CcSEcCtD
Oxybutynin—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.000592	CcSEcCtD
Oxybutynin—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000134	0.000588	CcSEcCtD
Oxybutynin—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000575	CcSEcCtD
Oxybutynin—Flushing—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000571	CcSEcCtD
Oxybutynin—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000559	CcSEcCtD
Oxybutynin—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00055	CcSEcCtD
Oxybutynin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000124	0.000545	CcSEcCtD
Oxybutynin—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.000541	CcSEcCtD
Oxybutynin—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000539	CcSEcCtD
Oxybutynin—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000536	CcSEcCtD
Oxybutynin—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000536	CcSEcCtD
Oxybutynin—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000515	CcSEcCtD
Oxybutynin—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000505	CcSEcCtD
Oxybutynin—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000497	CcSEcCtD
Oxybutynin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.000496	CcSEcCtD
Oxybutynin—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000493	CcSEcCtD
Oxybutynin—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000112	0.00049	CcSEcCtD
Oxybutynin—Malaise—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000483	CcSEcCtD
Oxybutynin—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000481	CcSEcCtD
Oxybutynin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000478	CcSEcCtD
Oxybutynin—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000471	CcSEcCtD
Oxybutynin—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000464	CcSEcCtD
Oxybutynin—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000463	CcSEcCtD
Oxybutynin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000456	CcSEcCtD
Oxybutynin—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000455	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000453	CcSEcCtD
Oxybutynin—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000451	CcSEcCtD
Oxybutynin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.000444	CcSEcCtD
Oxybutynin—Oedema—Prednisone—chronic obstructive pulmonary disease	9.96e-05	0.000437	CcSEcCtD
Oxybutynin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	9.96e-05	0.000437	CcSEcCtD
Oxybutynin—Infection—Prednisone—chronic obstructive pulmonary disease	9.89e-05	0.000435	CcSEcCtD
Oxybutynin—Shock—Prednisone—chronic obstructive pulmonary disease	9.8e-05	0.00043	CcSEcCtD
Oxybutynin—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	9.77e-05	0.000429	CcSEcCtD
Oxybutynin—Tachycardia—Prednisone—chronic obstructive pulmonary disease	9.72e-05	0.000427	CcSEcCtD
Oxybutynin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	9.67e-05	0.000425	CcSEcCtD
Oxybutynin—Anorexia—Prednisone—chronic obstructive pulmonary disease	9.49e-05	0.000417	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	9.07e-05	0.000399	CcSEcCtD
Oxybutynin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	9.06e-05	0.000398	CcSEcCtD
Oxybutynin—Insomnia—Prednisone—chronic obstructive pulmonary disease	9.01e-05	0.000396	CcSEcCtD
Oxybutynin—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	8.94e-05	0.000393	CcSEcCtD
Oxybutynin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	8.77e-05	0.000385	CcSEcCtD
Oxybutynin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	8.66e-05	0.00038	CcSEcCtD
Oxybutynin—Rash—Prednisolone—chronic obstructive pulmonary disease	8.64e-05	0.00038	CcSEcCtD
Oxybutynin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	8.63e-05	0.000379	CcSEcCtD
Oxybutynin—Fatigue—Prednisone—chronic obstructive pulmonary disease	8.59e-05	0.000377	CcSEcCtD
Oxybutynin—Headache—Prednisolone—chronic obstructive pulmonary disease	8.59e-05	0.000377	CcSEcCtD
Oxybutynin—Constipation—Prednisone—chronic obstructive pulmonary disease	8.52e-05	0.000374	CcSEcCtD
Oxybutynin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	8.21e-05	0.000361	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	8.14e-05	0.000358	CcSEcCtD
Oxybutynin—Nausea—Prednisolone—chronic obstructive pulmonary disease	8.14e-05	0.000358	CcSEcCtD
Oxybutynin—Urticaria—Prednisone—chronic obstructive pulmonary disease	7.91e-05	0.000348	CcSEcCtD
Oxybutynin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	7.87e-05	0.000346	CcSEcCtD
Oxybutynin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	7.34e-05	0.000322	CcSEcCtD
Oxybutynin—Asthenia—Prednisone—chronic obstructive pulmonary disease	7.15e-05	0.000314	CcSEcCtD
Oxybutynin—Pruritus—Prednisone—chronic obstructive pulmonary disease	7.05e-05	0.00031	CcSEcCtD
Oxybutynin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	6.81e-05	0.000299	CcSEcCtD
Oxybutynin—Dizziness—Prednisone—chronic obstructive pulmonary disease	6.59e-05	0.000289	CcSEcCtD
Oxybutynin—Vomiting—Prednisone—chronic obstructive pulmonary disease	6.33e-05	0.000278	CcSEcCtD
Oxybutynin—Rash—Prednisone—chronic obstructive pulmonary disease	6.28e-05	0.000276	CcSEcCtD
Oxybutynin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	6.27e-05	0.000276	CcSEcCtD
Oxybutynin—Headache—Prednisone—chronic obstructive pulmonary disease	6.24e-05	0.000274	CcSEcCtD
Oxybutynin—Nausea—Prednisone—chronic obstructive pulmonary disease	5.92e-05	0.00026	CcSEcCtD
Oxybutynin—CHRM1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	5.47e-05	0.00119	CbGpPWpGaD
Oxybutynin—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.46e-05	0.00118	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	5.45e-05	0.00118	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	5.43e-05	0.00118	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	5.4e-05	0.00117	CbGpPWpGaD
Oxybutynin—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.39e-05	0.00117	CbGpPWpGaD
Oxybutynin—CHRM2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	5.35e-05	0.00116	CbGpPWpGaD
Oxybutynin—CHRM1—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	5.22e-05	0.00113	CbGpPWpGaD
Oxybutynin—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.18e-05	0.00112	CbGpPWpGaD
Oxybutynin—CHRM2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	5.13e-05	0.00111	CbGpPWpGaD
Oxybutynin—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.11e-05	0.00111	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	5.08e-05	0.0011	CbGpPWpGaD
Oxybutynin—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	5.03e-05	0.00109	CbGpPWpGaD
Oxybutynin—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	5.01e-05	0.00109	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	4.97e-05	0.00108	CbGpPWpGaD
Oxybutynin—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	4.96e-05	0.00107	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	4.95e-05	0.00107	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	4.9e-05	0.00106	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	4.9e-05	0.00106	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	4.88e-05	0.00106	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	4.83e-05	0.00105	CbGpPWpGaD
Oxybutynin—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.66e-05	0.00101	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.62e-05	0.001	CbGpPWpGaD
Oxybutynin—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.6e-05	0.000996	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—GC—chronic obstructive pulmonary disease	4.49e-05	0.000973	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	4.41e-05	0.000955	CbGpPWpGaD
Oxybutynin—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	4.41e-05	0.000955	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	4.4e-05	0.000952	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	4.37e-05	0.000948	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	4.36e-05	0.000945	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	4.35e-05	0.000943	CbGpPWpGaD
Oxybutynin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	4.35e-05	0.000943	CbGpPWpGaD
Oxybutynin—CHRM2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	4.34e-05	0.000941	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	4.32e-05	0.000935	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.17e-05	0.000904	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.17e-05	0.000903	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	4.17e-05	0.000903	CbGpPWpGaD
Oxybutynin—CHRM1—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	4.11e-05	0.00089	CbGpPWpGaD
Oxybutynin—CHRM3—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	4.1e-05	0.000887	CbGpPWpGaD
Oxybutynin—CHRM2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	4.06e-05	0.000879	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	4e-05	0.000867	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.99e-05	0.000865	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.95e-05	0.000856	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.93e-05	0.000851	CbGpPWpGaD
Oxybutynin—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.89e-05	0.000842	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.88e-05	0.000841	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.87e-05	0.000839	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.86e-05	0.000836	CbGpPWpGaD
Oxybutynin—CHRM2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	3.85e-05	0.000835	CbGpPWpGaD
Oxybutynin—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.83e-05	0.000831	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.83e-05	0.000829	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.82e-05	0.000828	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.81e-05	0.000826	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.78e-05	0.000818	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	3.78e-05	0.000818	CbGpPWpGaD
Oxybutynin—CHRM2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.72e-05	0.000807	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.62e-05	0.000784	CbGpPWpGaD
Oxybutynin—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.57e-05	0.000774	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.57e-05	0.000773	CbGpPWpGaD
Oxybutynin—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.52e-05	0.000763	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.51e-05	0.000761	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.51e-05	0.00076	CbGpPWpGaD
Oxybutynin—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.39e-05	0.000734	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.36e-05	0.000728	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.36e-05	0.000728	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.36e-05	0.000727	CbGpPWpGaD
Oxybutynin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	3.34e-05	0.000725	CbGpPWpGaD
Oxybutynin—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.34e-05	0.000724	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.33e-05	0.000722	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	3.27e-05	0.000709	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.19e-05	0.000691	CbGpPWpGaD
Oxybutynin—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.1e-05	0.000673	CbGpPWpGaD
Oxybutynin—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.09e-05	0.00067	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.07e-05	0.000665	CbGpPWpGaD
Oxybutynin—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.06e-05	0.000664	CbGpPWpGaD
Oxybutynin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	3.06e-05	0.000664	CbGpPWpGaD
Oxybutynin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	3.05e-05	0.000662	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.04e-05	0.000659	CbGpPWpGaD
Oxybutynin—CHRM2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3e-05	0.000651	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.93e-05	0.000636	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.93e-05	0.000634	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.9e-05	0.000628	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.79e-05	0.000604	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.77e-05	0.000599	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.76e-05	0.000598	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.76e-05	0.000597	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.73e-05	0.000592	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.72e-05	0.00059	CbGpPWpGaD
Oxybutynin—CHRM1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	2.72e-05	0.000588	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.69e-05	0.000582	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.51e-05	0.000544	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.5e-05	0.000542	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.5e-05	0.000541	CbGpPWpGaD
Oxybutynin—CHRM1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2.49e-05	0.000538	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.48e-05	0.000537	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.47e-05	0.000536	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.46e-05	0.000534	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.46e-05	0.000532	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.45e-05	0.000531	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.44e-05	0.000529	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—GCLC—chronic obstructive pulmonary disease	2.43e-05	0.000525	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.42e-05	0.000525	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.37e-05	0.000512	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.36e-05	0.000512	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.36e-05	0.000511	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.36e-05	0.000511	CbGpPWpGaD
Oxybutynin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	2.36e-05	0.00051	CbGpPWpGaD
Oxybutynin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	2.35e-05	0.000509	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.34e-05	0.000506	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.33e-05	0.000506	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.28e-05	0.000495	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.24e-05	0.000486	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.24e-05	0.000485	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.22e-05	0.00048	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—CTGF—chronic obstructive pulmonary disease	2.21e-05	0.000479	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.16e-05	0.000468	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.16e-05	0.000467	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.13e-05	0.000462	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.11e-05	0.000457	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.06e-05	0.000447	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	2.04e-05	0.000442	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.04e-05	0.000442	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.96e-05	0.000425	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.96e-05	0.000424	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.94e-05	0.00042	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.9e-05	0.000411	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.88e-05	0.000408	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.86e-05	0.000403	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.8e-05	0.000391	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.79e-05	0.000387	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.77e-05	0.000383	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.76e-05	0.00038	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.73e-05	0.000375	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.72e-05	0.000374	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.72e-05	0.000373	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.71e-05	0.000371	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.71e-05	0.000371	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.71e-05	0.00037	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.7e-05	0.000368	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.68e-05	0.000363	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.65e-05	0.000357	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.65e-05	0.000357	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.63e-05	0.000354	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.61e-05	0.000349	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.61e-05	0.000348	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.6e-05	0.000347	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.59e-05	0.000344	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.56e-05	0.000339	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.53e-05	0.000332	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.48e-05	0.000322	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.48e-05	0.000321	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.48e-05	0.000321	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.48e-05	0.00032	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.47e-05	0.000318	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.46e-05	0.000317	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.45e-05	0.000314	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.43e-05	0.00031	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.41e-05	0.000305	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.34e-05	0.000289	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.33e-05	0.000289	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.33e-05	0.000287	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.32e-05	0.000287	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.32e-05	0.000286	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.32e-05	0.000286	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.31e-05	0.000285	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.31e-05	0.000284	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.26e-05	0.000273	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.25e-05	0.00027	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.24e-05	0.000268	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.22e-05	0.000265	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.22e-05	0.000264	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.21e-05	0.000263	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.21e-05	0.000262	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.21e-05	0.000261	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.2e-05	0.00026	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.2e-05	0.00026	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.2e-05	0.000259	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.19e-05	0.000258	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.16e-05	0.000251	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.16e-05	0.000251	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.15e-05	0.000249	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.15e-05	0.000248	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.14e-05	0.000247	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.08e-05	0.000234	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.08e-05	0.000234	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.08e-05	0.000233	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.06e-05	0.000231	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.02e-05	0.000221	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.02e-05	0.00022	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—ALB—chronic obstructive pulmonary disease	1.01e-05	0.000218	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1e-05	0.000217	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.68e-06	0.00021	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—NOS3—chronic obstructive pulmonary disease	9.63e-06	0.000209	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.59e-06	0.000208	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	9.48e-06	0.000205	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.34e-06	0.000202	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.21e-06	0.000199	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.87e-06	0.000192	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.86e-06	0.000192	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.84e-06	0.000191	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.75e-06	0.00019	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	8.65e-06	0.000187	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	8.47e-06	0.000183	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.46e-06	0.000183	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.44e-06	0.000183	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.35e-06	0.000181	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.27e-06	0.000179	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	8.1e-06	0.000175	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.08e-06	0.000175	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.05e-06	0.000174	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.98e-06	0.000173	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.97e-06	0.000173	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.59e-06	0.000164	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.44e-06	0.000161	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	7.33e-06	0.000159	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.17e-06	0.000155	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.14e-06	0.000155	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.07e-06	0.000153	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	7.02e-06	0.000152	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.82e-06	0.000148	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.79e-06	0.000147	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.73e-06	0.000146	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.65e-06	0.000144	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.56e-06	0.000142	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.48e-06	0.00014	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.46e-06	0.00014	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.4e-06	0.000139	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.25e-06	0.000135	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.11e-06	0.000132	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	6.02e-06	0.00013	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.82e-06	0.000126	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.8e-06	0.000126	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.79e-06	0.000125	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.76e-06	0.000125	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.75e-06	0.000124	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.72e-06	0.000124	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.34e-06	0.000116	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.33e-06	0.000115	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.27e-06	0.000114	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.24e-06	0.000113	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.22e-06	0.000113	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.17e-06	0.000112	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.4e-06	9.53e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.38e-06	9.5e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.34e-06	9.41e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.03e-06	8.72e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.01e-06	8.69e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.97e-06	8.61e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.94e-06	8.53e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.77e-06	8.16e-05	CbGpPWpGaD
